tiprankstipranks
Trending News
More News >
Fortress Biotech (FBIO)
NASDAQ:FBIO
US Market

Fortress Biotech (FBIO) Financial Statements

Compare
1,571 Followers

Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently $115.46M. The company's EPS TTM is $0.11; its P/E ratio is -13.90; Fortress Biotech is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 57.67M$ 84.51M$ 75.74M$ 68.79M$ 45.60M
Gross Profit$ 36.80M$ 61.62M$ 44.97M$ 36.71M$ 31.00M
Operating Income$ -110.38M$ -142.34M$ -203.56M$ -188.54M$ -94.27M
EBITDA$ -104.49M$ -135.72M$ -193.69M$ -146.17M$ -87.82M
Net Income$ -46.00M$ -60.64M$ -86.58M$ -64.70M$ -46.53M
Balance Sheet
Cash & Short-Term Investments$ 57.26M$ 80.93M$ 178.27M$ 305.74M$ 233.35M
Total Assets$ 144.22M$ 167.53M$ 294.30M$ 396.50M$ 333.41M
Total Debt$ 75.96M$ 88.59M$ 127.34M$ 74.98M$ 89.08M
Net Debt$ 18.70M$ 7.67M$ -50.92M$ -230.77M$ -144.28M
Total Liabilities$ 145.87M$ 165.94M$ 244.28M$ 170.63M$ 136.41M
Stockholders' Equity$ 22.74M$ 22.54M$ 41.72M$ 108.67M$ 100.34M
Cash Flow
Free Cash Flow$ -95.19M$ -136.32M$ -182.46M$ -132.89M$ -90.85M
Operating Cash Flow$ -80.19M$ -128.22M$ -179.40M$ -116.54M$ -83.68M
Investing Cash Flow$ -15.00M$ -2.10M$ -22.93M$ 40.51M$ -7.16M
Financing Cash Flow$ 70.64M$ 32.74M$ 75.32M$ 148.99M$ 172.41M
Currency in USD

Fortress Biotech Earnings and Revenue History

Fortress Biotech Debt to Assets

Fortress Biotech Cash Flow

Fortress Biotech Forecast EPS vs Actual EPS